By integrating mRNA, isoform, and protein-level analyses with TP53 mutation status and clinicopathologic data, we aimed to clarify the role of TP73 in breast cancer biology, define its interplay with TP53, and assess its potential as a prognostic and therapeutic biomarker. The gene discussed is TP53; the disease is breast cancer.